https://clinicaltrials.gov/ct2/show/NCT03843125?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F01%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Intervention : Drug: Baricitinib
Sponsors : Eli Lilly and Company; Incyte Corporation
Not yet recruiting
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
NCT03843125
Fri, 15 Feb 2019 12:00:00 EST
